Free Trial
NASDAQ:NYXH

Nyxoah (NYXH) Stock Price, News & Analysis

Nyxoah logo
$6.25 -0.03 (-0.48%)
As of 09:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nyxoah Stock (NASDAQ:NYXH)

Key Stats

Today's Range
$6.20
$6.20
50-Day Range
$6.17
$8.28
52-Week Range
$5.55
$11.87
Volume
150 shs
Average Volume
104,737 shs
Market Capitalization
$212.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00
Consensus Rating
Buy

Company Overview

Nyxoah Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

NYXH MarketRank™: 

Nyxoah scored higher than 44% of companies evaluated by MarketBeat, and ranked 654th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nyxoah has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nyxoah has received no research coverage in the past 90 days.

  • Read more about Nyxoah's stock forecast and price target.
  • Earnings Growth

    Earnings for Nyxoah are expected to grow in the coming year, from ($1.91) to ($1.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nyxoah is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nyxoah is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nyxoah has a P/B Ratio of 2.56. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nyxoah's valuation and earnings.
  • Percentage of Shares Shorted

    0.94% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently increased by 29.87%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nyxoah does not currently pay a dividend.

  • Dividend Growth

    Nyxoah does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.94% of the float of Nyxoah has been sold short.
  • Short Interest Ratio / Days to Cover

    Nyxoah has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nyxoah has recently increased by 29.87%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nyxoah has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Nyxoah this week, compared to 2 articles on an average week.
  • Search Interest

    1 people have searched for NYXH on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nyxoah insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.11% of the stock of Nyxoah is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Nyxoah's insider trading history.
Receive NYXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nyxoah and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NYXH Stock News Headlines

Nyxoah FY2025 EPS Forecast Decreased by Cantor Fitzgerald
Nyxoah: High-Risk High-Reward Medtech To Own
This is my Christian duty
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.tc pixel
Q2 2025 Nyxoah SA Earnings Call Transcript
Nyxoah SA (NYXH) Q2 2025 Earnings Call Transcript
See More Headlines

NYXH Stock Analysis - Frequently Asked Questions

Nyxoah's stock was trading at $8.00 on January 1st, 2025. Since then, NYXH shares have decreased by 21.5% and is now trading at $6.28.

Nyxoah SA (NASDAQ:NYXH) announced its quarterly earnings results on Monday, August, 18th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.62) by $0.01. The firm had revenue of $1.58 million for the quarter, compared to the consensus estimate of $1.33 million. Nyxoah had a negative trailing twelve-month return on equity of 79.18% and a negative net margin of 1,541.84%.
Read the conference call transcript
.

Nyxoah (NYXH) raised $83 million in an initial public offering (IPO) on Friday, July 2nd 2021. The company issued 2,760,000 shares at $30.00 per share.

Top institutional shareholders of Nyxoah include Vestal Point Capital LP (4.12%), Franklin Resources Inc. (0.87%), Kovack Advisors Inc. (0.17%) and Shay Capital LLC (0.15%).

Shares of NYXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nyxoah investors own include PayPal (PYPL), Confluent (CFLT), Datadog (DDOG), Baidu (BIDU), Arcadia Biosciences (RKDA), SEA (SE) and ZoomInfo Technologies (ZI).

Company Calendar

Last Earnings
8/18/2025
Today
8/29/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NYXH
CIK
1857190
Employees
110
Year Founded
N/A

Price Target and Rating

High Price Target
$16.00
Low Price Target
$14.00
Potential Upside/Downside
+138.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.30)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$64.10 million
Net Margins
-1,541.84%
Pretax Margin
-1,508.78%
Return on Equity
-79.18%
Return on Assets
-54.92%

Debt

Debt-to-Equity Ratio
0.29
Current Ratio
2.63
Quick Ratio
2.38

Sales & Book Value

Annual Sales
$4.89 million
Price / Sales
43.74
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.45 per share
Price / Book
2.56

Miscellaneous

Outstanding Shares
34,060,000
Free Float
28,232,000
Market Cap
$213.90 million
Optionable
Not Optionable
Beta
1.61

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:NYXH) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners